Director at Adicet Bio (ACET) receives 4,200 stock options award
Rhea-AI Filing Summary
Adicet Bio, Inc. director Lloyd Klickstein received a grant of stock options covering 4,200 shares of common stock. The options have an exercise price of $8.10 per share and expire on June 20, 2036. They vest in full on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders, subject to his continued service on the board. This is a routine equity compensation award and does not involve any open-market buying or selling of shares.
Positive
- None.
Negative
- None.
Insights
Routine director stock option grant with standard vesting terms.
Director Lloyd Klickstein was granted options on 4,200 Adicet Bio shares at an exercise price of $8.10, expiring on June 20, 2036. The filing classifies this as a grant or award, not an open-market transaction.
The options vest in full on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders, contingent on continued board service. Such awards are a common way to align director incentives with shareholders and are typically viewed as routine rather than thesis-changing events.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Klickstein Lloyd
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 4,200 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 4,200 shares (Direct)
Footnotes (1)
- F1. These shares shall vest in full on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on the Issuer's board of directors.
Key Figures
Options granted: 4,200 options
Exercise price: $8.10 per share
Underlying shares: 4,200 shares
+2 more
5 metrics
Options granted
4,200 options
Stock Option (Right to Buy) granted to director
Exercise price
$8.10 per share
Conversion or exercise price of stock options
Underlying shares
4,200 shares
Common stock underlying the options
Total options after grant
4,200 options
Total derivative shares following transaction
Expiration date
June 20, 2036
Option expiration date
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, annual meeting of stockholders, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 8.1000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-20T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
annual meeting of stockholders financial
"the date of the next annual meeting of stockholders following the grant date"
board of directors financial
"subject to the Reporting Person's continued service on the Issuer's board of directors"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
FAQ
What insider transaction did Adicet Bio (ACET) disclose for Lloyd Klickstein?
Adicet Bio disclosed that director Lloyd Klickstein received a grant of stock options for 4,200 shares of common stock. The options are a compensation award, not an open-market purchase or sale, and increase his potential future equity exposure to the company.
How many Adicet Bio (ACET) stock options were granted to Lloyd Klickstein and at what price?
Lloyd Klickstein was granted options on 4,200 Adicet Bio common shares with an exercise price of $8.10 per share. This means he can choose to buy those shares at $8.10 in the future, any time before the options expire, once they vest.
When do Lloyd Klickstein’s Adicet Bio (ACET) stock options vest?
The options vest in full on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders. Vesting is conditioned on Klickstein’s continued service on Adicet Bio’s board, so leaving the board early could affect the vesting outcome.
What is the expiration date of Lloyd Klickstein’s Adicet Bio (ACET) stock options?
The granted stock options expire on June 20, 2036, providing roughly a decade-long exercise window after vesting. If the options are not exercised by that expiration date, they will lapse and no longer give Klickstein the right to purchase Adicet Bio shares.
How many Adicet Bio (ACET) options does Lloyd Klickstein hold after this grant?
After this transaction, Lloyd Klickstein holds stock options representing 4,200 shares of Adicet Bio common stock. The filing does not list additional derivative positions, so this grant establishes his reported option holdings at that level in this specific disclosure.
AI-generated analysis. How Rhea-AI works. Not financial advice.
